Results 31 to 40 of about 1,649,340 (344)

Nitric oxide for respiratory failure in infants born at or near term.

open access: yesCochrane Database of Systematic Reviews, 2017
BACKGROUND Nitric oxide is a major endogenous regulator of vascular tone. Inhaled nitric oxide gas has been investigated as a treatment for persistent pulmonary hypertension of the newborn.
K. Barrington   +3 more
semanticscholar   +1 more source

Transcription Profiles Associated with Inducible Adhesion in Candida parapsilosis

open access: yesmSphere, 2021
Invasive CandidaC. albicansalbicans CandidaC.
Joseph M. Bliss   +6 more
doaj   +1 more source

Ex vivo expansion of circulating tumour cells (CTCs)

open access: yesScientific Reports, 2023
Circulating tumour cells (CTCs) are a critical intermediate step in the process of cancer metastasis. The reliability of CTC isolation/purification has limited both the potential to report on metastatic progression and the development of CTCs as targets ...
Bashir M. Mohamed   +16 more
doaj   +1 more source

Microbial exopolysaccharide production by polyextremophiles in the adaptation to multiple extremes

open access: yesFEBS Letters, EarlyView.
Polyextremophiles are microorganisms that endure multiple extreme conditions by various adaptation strategies that also include the production of exopolysaccharides (EPSs). This review provides an integrated perspective on EPS biosynthesis, function, and regulation in these organisms, emphasizing their critical role in survival and highlighting their ...
Tracey M Gloster, Ebru Toksoy Öner
wiley   +1 more source

MicroRNA 219-5p inhibits alveolarization by reducing platelet derived growth factor receptor-alpha

open access: yesRespiratory Research, 2021
Background MicroRNA (miR) are small conserved RNA that regulate gene expression post-transcription. Previous genome-wide analysis studies in preterm infants indicate that pathways of miR 219-5p are important in infants with Bronchopulmonary Dysplasia ...
Amelia Freeman   +10 more
doaj   +1 more source

Targeted protein degradation in oncology: novel therapeutic opportunity for solid tumours?

open access: yesMolecular Oncology, EarlyView.
Current anticancer therapies are limited by the occurrence of resistance and undruggability of most proteins. Targeted protein degraders are novel, promising agents that trigger the selective degradation of previously undruggable proteins through the recruitment of the ubiquitin–proteasome machinery. Their mechanism of action raises exciting challenges,
Noé Herbel, Sophie Postel‐Vinay
wiley   +1 more source

High flow nasal cannula for respiratory support in preterm infants.

open access: yesCochrane Database of Systematic Reviews, 2016
BACKGROUND High flow nasal cannulae (HFNC) are small, thin, tapered binasal tubes that deliver oxygen or blended oxygen/air at gas flows of more than 1 L/min.
D. Wilkinson   +4 more
semanticscholar   +1 more source

Landscape of BRAF transcript variants in human cancer

open access: yesMolecular Oncology, EarlyView.
We investigate the annotation of BRAF variants, focusing on protein‐coding BRAF‐220 (formerly BRAF‐reference) and BRAF‐204 (BRAF‐X1). The IsoWorm pipeline allows us to quantify these variants in human cancer, starting from RNA‐sequencing data. BRAF‐204 is more abundant than BRAF‐220 and impacts patient survival.
Maurizio S. Podda   +5 more
wiley   +1 more source

How do breast cancer surgery scars impact survivorship? Findings from a nationwide survey in the United States

open access: yesBMC Cancer, 2019
Background The surgical treatment of breast cancer has been associated with negative consequences for patients’ body image, sexual functioning, mental health, and social adjustment.
Jennifer Gass   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy